PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
15.13%
Revenue growth above 1.5x MU's 8.06%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
13.22%
Gross profit growth similar to MU's 13.96%. Walter Schloss would assume both firms track common industry trends.
24.19%
EBIT growth above 1.5x MU's 15.18%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
24.19%
Operating income growth above 1.5x MU's 15.18%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
14.99%
Net income growth at 50-75% of MU's 23.56%. Martin Whitman would question fundamental disadvantages in expenses or demand.
13.64%
EPS growth at 50-75% of MU's 21.19%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
15.00%
Diluted EPS growth at 50-75% of MU's 21.92%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.84%
Share reduction more than 1.5x MU's 1.94%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-1.25%
Reduced diluted shares while MU is at 1.06%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
1.58%
Dividend growth of 1.58% while MU is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
150.00%
OCF growth above 1.5x MU's 19.58%. David Dodd would confirm a clear edge in underlying cash generation.
185.53%
FCF growth above 1.5x MU's 33.61%. David Dodd would verify if the firm’s strategic investments yield superior returns.
118.59%
10Y revenue/share CAGR under 50% of MU's 261.42%. Michael Burry would suspect a lasting competitive disadvantage.
121.41%
5Y revenue/share CAGR at 50-75% of MU's 210.91%. Martin Whitman would worry about a lagging mid-term growth trajectory.
89.07%
3Y revenue/share CAGR 1.25-1.5x MU's 63.94%. Bruce Berkowitz might see better product or regional expansions than the competitor.
95.20%
10Y OCF/share CAGR under 50% of MU's 930.21%. Michael Burry would worry about a persistent underperformance in cash creation.
263.88%
Below 50% of MU's 1533.09%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
584.66%
3Y OCF/share CAGR above 1.5x MU's 222.91%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
209.42%
Net income/share CAGR at 50-75% of MU's 384.55%. Martin Whitman might question if the firm’s product or cost base lags behind.
407.77%
Below 50% of MU's 1116.87%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
325.96%
3Y net income/share CAGR 1.25-1.5x MU's 229.15%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
142.26%
10Y equity/share CAGR in line with MU's 154.82%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
39.06%
Below 50% of MU's 212.33%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
29.74%
Below 50% of MU's 92.13%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
65.59%
3Y dividend/share CAGR of 65.59% while MU is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
24.28%
AR growth well above MU's 14.47%. Michael Burry fears inflated revenue or higher default risk in the near future.
4.14%
Inventory growth well above MU's 0.76%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.09%
Negative asset growth while MU invests at 10.95%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-3.41%
We have a declining book value while MU shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-6.20%
We’re deleveraging while MU stands at 2.95%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
1.22%
R&D dropping or stable vs. MU's 16.74%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
7.03%
SG&A growth well above MU's 2.62%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.